Star7 S.p.A. (BIT:STAR7)
Italy · Delayed Price · Currency is EUR 6.10
0.00 (0.00%)
At close: Aug 1, 2025, 5:30 PM CET
Verve Therapeutics Revenue
In the year 2024, Star7 had annual revenue of 121.27M EUR with 14.95% growth. Star7 had revenue of 60.81M in the half year ending December 31, 2024, with 37.81% growth.
Revenue
121.27M
Revenue Growth
+14.95%
P/S Ratio
0.45
Revenue / Employee
84.33K
Employees
1,438
Market Cap
54.90M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 121.27M | 15.77M | 14.95% |
| Dec 31, 2023 | 105.50M | 21.31M | 25.31% |
| Dec 31, 2022 | 84.19M | 24.89M | 41.98% |
| Dec 31, 2021 | 59.29M | 15.15M | 34.32% |
| Dec 31, 2020 | 44.14M | -7.84M | -15.08% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Leonardo S.p.a. | 18.70B |
| Poste Italiane | 13.78B |
| Prysmian | 18.98B |
| Fincantieri | 8.85B |
| Iveco Group | 14.81B |
| Maire | 6.70B |
| Webuild | 12.30B |
| Interpump Group | 2.05B |